GRADE tables for review 1a. imaging for suspected glioma and meningioma

Table 24. Clinical evidence profile: colour map images derived from PWI, MRS and the following cut-off data: 1.75 rCBV, 1.5 for Choline, 1.5 Cho/NAA (semi quantitative analysis from Caulo 2014) (PDF, 233K)

Table 25. Clinical evidence profile: conventional MRI sequences (qualitative analysis from Caulo 2014) (PDF, 233K)

Table 26. Clinical evidence profile: DWI (ADC maps generated), DTI, MRS (Cho/Cr, NAA/Cr, Cho/NAA, lactate/Cr, and lipids/Cr) and PWI (blood volume and mean transit maps were generated) with a cut-off value of −0.3096 (quantitative analysis from Caulo 2014) (PDF, 245K)

Table 27. Clinical evidence profile: DWI (ADC maps generated), DTI, MRS (Cho/Cr, NAA/Cr, Cho/NAA, lactate/Cr, and lipids/Cr) and PWI (blood volume and mean transit maps were generated) with a cut-off value of −0.3096 without including oligodendroglioma (ODG) (identification of high- versus low-grade glioma) (quantitative analysis from Caulo 2014) (PDF, 228K)

Table 28. Summary clinical evidence profile: conventional MRI (Law 2003) (PDF, 227K)

Table 29. Clinical evidence profile: perfusion MRI (Law 2003) (PDF, 254K)

Table 30. Clinical evidence profile: threshold values for Cho/Cr from perfusion MRS (Law 2003) (PDF, 265K)

Table 31. Clinical evidence profile: thresholds for Cho/NAA from perfusion MRI (Law 2003) (PDF, 257K)

Table 32. Clinical evidence profile: threshold values for rCBV and Cho/NAA ratio together (Law 2003) (PDF, 235K)

Table 33. Clinical evidence profile: conventional MRI (Zou 2011) (PDF, 233K)

Table 34. Clinical evidence profile: combination of apparent diffusion coefficient (ADC) and N-acetylaspartate/choline ratio (NAA/Cho) (Zou 2011) (PDF, 233K)

Table 35. Clinical evidence profile: T2 WI - FLAIR GLCM Cluster Shade (PDF, 233K)

Table 36. Clinical evidence profile: T1W1-CE GLCM Entropy on the T1W1-CE sequence (PDF, 227K)

Table 37. Clinical evidence profile: Summary clinical evidence profile for combined features of conventional MRI and DWI (PDF, 228K)

GRADE tables for review 3a. managing inoperable, incompletely excised or recurrent meningioma

Table 52. Clinical evidence profile: Radiotherapy versus observation in patients with incompletely resected WHO grade I-III meningioma (PDF, 258K)

Table 53. Clinical evidence profile: Radiotherapy versus observation in patients with incompletely resected benign meningioma (PDF, 255K)

Table 54. Clinical evidence profile: Radiotherapy versus observation in patients with incompletely resected malignant meningioma (PDF, 272K)

Table 55. Clinical evidence profile: Radiotherapy versus observation in patients with incompletely resected atypical meningioma? (PDF, 310K)

Table 56. Clinical evidence profile: Radiotherapy versus observation in patients with incompletely resected WHO grade II meningioma (NOS)? (PDF, 275K)

Table 57. Clinical evidence profile: Radiotherapy versus observation in patients with incompletely resected WHO grade II atypical meningioma located in the skull base (PDF, 327K)

Table 58. Clinical evidence profile: Radiotherapy versus observation in patients with incompletely resected primary sphenoid wing meningioma (PDF, 274K)

Table 59. Clinical evidence profile: Radiotherapy versus observation in patients with incompletely resected meningioma involving the major venous sinus (PDF, 251K)

Table 60. Clinical evidence profile: Radiotherapy versus surgery in patients with recurrent atypical meningioma (PDF, 255K)

Table 61. Clinical evidence profile: Radiotherapy versus observation in patients with incompletely resected recurrent sphenoid wing meningioma (PDF, 272K)

GRADE tables for review 3b. techniques for radiotherapy for meningioma

Table 62. Clinical evidence profile: Stereotactic radiosurgery (SRS) or fractionated stereotactic radiotherapy (FSRT) in patients with cavernous sinus meningioma (PDF, 274K)

Table 63. Clinical evidence profile: Fractionated stereotactic radiotherapy (FSRT) versus hypo-fractionated stereotactic radiotherapy (hFRST) in patients with grade I meningioma (PDF, 251K)

Table 64. Clinical evidence profile: Stereotactic radiosurgery (SRS) versus fractionated stereotactic radiotherapy (FRST) in patients with basal meningioma (PDF, 201K)

Table 65. Clinical evidence profile: Stereotactic radiosurgery (SRS) versus intensity-modulated radiotherapy (IMRT) in patients with atypical meningioma (PDF, 200K)

Table 66. Clinical evidence profile: Fractionated stereotactic radiotherapy (FSRT) versus hypo-fractionated stereotactic radiotherapy (hFSRT) in patients with intracranial meningioma (PDF, 274K)

Table 67. Clinical evidence profile: Stereotactic radiosurgery (SRS) versus fractionated stereotactic radiotherapy (FSRT) in patients with intracranial meningioma (PDF, 207K)

GRADE tables for review 5b. follow-up for meningioma

Not applicable - no evidence was identified.